Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption.

Megraud, Francis;Coenen, Samuel;Versporten, Ann;Kist, Manfred;Huang, Te-Din;et.al.
(2013) Gut — Vol. 62, n° 1, p. 34-42 (2013)

Files

MegraudFGlupczynski-Gut2013.pdf
  • Restricted Access
  • Adobe PDF
  • 772.4 KB
Request a copy

Details

Authors
  • Megraud, Francis
    Author
  • Coenen, Samuel
    Author
  • Versporten, Ann
    Author
  • Kist, Manfred
    Author
  • Glupczynski, GeraldUCLouvain
    Author
  • Huang, Te-DinStudy group participants
    Collaborator
Show more
Abstract
In many countries the high rate of clarithromycin resistance no longer allows its empirical use in standard anti-H pylori regimens. The knowledge of outpatient antibiotic consumption may provide a simple tool to predict the susceptibility of H pylori to quinolones and to macrolides and to adapt the treatment strategies.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Megraud, F., Coenen, S., Versporten, A., Kist, M., Lopez-Brea, M., Hirschl, A. M., Andersen, L. P., Goossens, H., & Glupczynski, G. (2013). Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut, 62(1), 34-42. https://doi.org/10.1136/gutjnl-2012-302254 (Original work published 2013)